Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
25.59
+0.87 (3.52%)
At close: May 1, 2024, 4:00 PM
25.99
+0.40 (1.56%)
After-hours: May 1, 2024, 6:33 PM EDT
Insmed Revenue
In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth. Revenue in the quarter ending December 31, 2023 was $83.69M with 41.13% year-over-year growth.
Revenue (ttm)
$305.21M
Revenue Growth
+24.39%
P/S Ratio
12.45
Revenue / Employee
$334,658
Employees
912
Market Cap
3.80B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
Dec 31, 2019 | 136.47M | 126.63M | 1,287.56% |
Dec 31, 2018 | 9.84M | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 11.50M | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 4.42M | -2.50M | -36.18% |
Dec 31, 2010 | 6.92M | -3.45M | -33.28% |
Dec 31, 2009 | 10.37M | -1.33M | -11.33% |
Dec 31, 2008 | 11.70M | 4.12M | 54.32% |
Dec 31, 2007 | 7.58M | 6.56M | 639.61% |
Dec 31, 2006 | 1.03M | 894.00K | 682.44% |
Dec 31, 2005 | 131.00K | -6.00K | -4.38% |
Dec 31, 2004 | 137.00K | -13.00K | -8.67% |
Dec 31, 2003 | 150.00K | -1.81M | -92.33% |
Dec 31, 2002 | 1.96M | 1.66M | 560.47% |
Dec 31, 2001 | 296.00K | 236.00K | 393.33% |
Dec 31, 2000 | 60.00K | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.66B |
PACS Group | 3.11B |
Alkermes | 1.66B |
Integer Holdings | 1.63B |
RadNet | 1.62B |
Ultragenyx Pharmaceutical | 434.25M |
TransMedics Group | 241.62M |
Alvotech | 93.38M |
INSM News
- 7 days ago - Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 - PRNewsWire
- 27 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference - PRNewsWire
- 2 months ago - Insmed To Present at Three March Conferences - PRNewsWire
- 2 months ago - Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health - PRNewsWire
- 2 months ago - Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024 - PRNewsWire
- 4 months ago - Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire